BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 12559863)

  • 1. Overview of the main outcomes in breast-cancer prevention trials.
    Cuzick J; Powles T; Veronesi U; Forbes J; Edwards R; Ashley S; Boyle P
    Lancet; 2003 Jan; 361(9354):296-300. PubMed ID: 12559863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.
    Chlebowski RT; Collyar DE; Somerfield MR; Pfister DG
    J Clin Oncol; 1999 Jun; 17(6):1939-55. PubMed ID: 10561236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of breast cancer in high-risk women.
    Kardinal CG; Veith R
    J La State Med Soc; 1999 Apr; 151(4):198-201. PubMed ID: 10234895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen for prevention of breast cancer.
    Med Lett Drugs Ther; 1999 Jan; 41(1043):1-2. PubMed ID: 9924486
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of a new prevention maintenance therapy for postmenopausal women.
    Jordan VC
    Recent Results Cancer Res; 1999; 151():96-109. PubMed ID: 10337721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemoprevention of breast cancer. Impact of a new therapeutic strategy].
    Kattan J; Ghosn M
    J Med Liban; 1999; 47(5):284-5. PubMed ID: 10887527
    [No Abstract]   [Full Text] [Related]  

  • 8. Status of antiestrogen breast cancer prevention trials.
    Powles TJ
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):28-31. PubMed ID: 9556788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The breast cancer prevention trial (P-1 study). The role of tamoxifen in preventing breast cancer.
    Overmoyer BA
    Cleve Clin J Med; 1999 Jan; 66(1):33-40. PubMed ID: 9926629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of breast cancer in the older patient.
    Minton SE
    Hematol Oncol Clin North Am; 2000 Feb; 14(1):113-30. PubMed ID: 10680075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.
    Cummings SR; Eckert S; Krueger KA; Grady D; Powles TJ; Cauley JA; Norton L; Nickelsen T; Bjarnason NH; Morrow M; Lippman ME; Black D; Glusman JE; Costa A; Jordan VC
    JAMA; 1999 Jun; 281(23):2189-97. PubMed ID: 10376571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
    Fisher B; Costantino JP; Wickerham DL; Redmond CK; Kavanah M; Cronin WM; Vogel V; Robidoux A; Dimitrov N; Atkins J; Daly M; Wieand S; Tan-Chiu E; Ford L; Wolmark N
    J Natl Cancer Inst; 1998 Sep; 90(18):1371-88. PubMed ID: 9747868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.
    Powles T; Eeles R; Ashley S; Easton D; Chang J; Dowsett M; Tidy A; Viggers J; Davey J
    Lancet; 1998 Jul; 352(9122):98-101. PubMed ID: 9672274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.
    Jordan VC
    Breast Cancer Res Treat; 1995; 36(3):267-85. PubMed ID: 8573710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen, raloxifene, and the prevention of breast cancer.
    Jordan VC; Morrow M
    Endocr Rev; 1999 Jun; 20(3):253-78. PubMed ID: 10368771
    [No Abstract]   [Full Text] [Related]  

  • 16. Future possibilities in the prevention of breast cancer: breast cancer prevention trials.
    Cuzick J
    Breast Cancer Res; 2000; 2(4):258-63. PubMed ID: 11250718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen in postmenopausal women a safety perspective.
    Robinson E; Kimmick GG; Muss HB
    Drugs Aging; 1996 May; 8(5):329-37. PubMed ID: 8935395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tamoxifen dilemma.
    White IN
    Carcinogenesis; 1999 Jul; 20(7):1153-60. PubMed ID: 10383884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Fisher B; Costantino JP; Redmond CK; Fisher ER; Wickerham DL; Cronin WM
    J Natl Cancer Inst; 1994 Apr; 86(7):527-37. PubMed ID: 8133536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A brief review of the current breast cancer prevention trials and proposals for future trials.
    Cuzick J
    Eur J Cancer; 2000 Jun; 36(10):1298-302. PubMed ID: 10882870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.